ZL-1310

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

Study Name:
An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

Targeted Disease(s):
Lung Cancer

Purpose of Study:

Evaluate safety, tolerability, and pharmacokinetics of ZL-1310 in subjects with small cell lung cancer.

Study Dates:
January 1, 2024 - July 30, 2027

Type of Study:
Pre-Market

Study Design:
Controlled Design

Study Location:
Nationwide

Lead Institution:
Zai Lab

ClinicalTrails.gov Identifier:
NCT06179069

Register for Trial
Freedom From Smoking Clinic
Detroit, MI | May 29, 2024
Asthma Basics Workshop - National
, | Jun 18, 2024